{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:41:49Z","timestamp":1768704109522,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T00:00:00Z","timestamp":1562457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T00:00:00Z","timestamp":1562457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21 MH076651-01"],"award-info":[{"award-number":["R21 MH076651-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R21 MH076651-01"],"award-info":[{"award-number":["R21 MH076651-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008673","name":"Center for AIDS Research, University of California, San Diego","doi-asserted-by":"crossref","award":["International Pilot Grant P30 AI036214"],"award-info":[{"award-number":["International Pilot Grant P30 AI036214"]}],"id":[{"id":"10.13039\/100008673","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13365-019-00783-6","type":"journal-article","created":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T22:18:28Z","timestamp":1562537908000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Blood amyloid-\u03b2 protein isoforms are affected by HIV-1 in a subtype-dependent pattern"],"prefix":"10.1007","volume":"26","author":[{"name":"The HIV Neurobehavioral Research Center (HNRC) Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-105X","authenticated-orcid":false,"given":"S\u00e9rgio M.","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clea E.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indianara","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiri","family":"Batistela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florin","family":"Vaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,7]]},"reference":[{"key":"783_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2010.03.073","volume":"475","author":"MY Aksenov","year":"2010","unstructured":"Aksenov MY, Aksenova MV, Mactutus CF et al (2010) HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci Lett 475:174\u2013178","journal-title":"Neurosci Lett"},{"key":"783_CR2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s13365-013-0215-5","volume":"19","author":"SM de Almeida","year":"2013","unstructured":"de Almeida SM, Ribeiro CE, de Pereira AP et al (2013) Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil. J Neurovirol 19:550\u2013556","journal-title":"J Neurovirol"},{"key":"783_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QAI.0000000000001666","volume":"78","author":"SM de Almeida","year":"2018","unstructured":"de Almeida SM, Tang B, Ribeiro CE et al (2018a) Neprilysin in the cerebrospinal fluid and serum of patients infected with HIV1-subtypes C and B. J Acquir Immune Defic Syndr 78:248\u2013256","journal-title":"J Acquir Immune Defic Syndr"},{"key":"783_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13365-017-0591-3","volume":"24","author":"SM de Almeida","year":"2018","unstructured":"de Almeida SM, Ribeiro CE, Rotta I et al (2018b) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28\u201340","journal-title":"J Neurovirol"},{"key":"783_CR5","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders. DSM-5. Washington, DC: American Psychiatric Association","DOI":"10.1176\/appi.books.9780890425596"},{"key":"783_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/iub.1106","volume":"65","author":"IE Andras","year":"2013","unstructured":"Andras IE, Toborek M (2013) Amyloid beta accumulation in HIV-1-infected brain: the role of the blood brain barrier. IUBMB Life 65:43\u201349","journal-title":"IUBMB Life"},{"key":"783_CR7","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade (2017) Programa Nacional de DST\/AIDS. \nhttp:\/\/www.aids.gov.br\/assistencia\/manualdst\/item12.htm\n\n. Accessed 20 Dec 2018"},{"key":"783_CR8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K et al (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65:1490\u20131492","journal-title":"Neurology"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"e95500","DOI":"10.1371\/journal.pone.0095500","volume":"9","author":"LAM Brown","year":"2014","unstructured":"Brown LAM, Jin J, Ferrell D et al (2014) Efavirenz promotes b-secretase expression and increased Ab1\u201340,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND). PLoS One 9:e95500. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0095500","journal-title":"PLoS One"},{"key":"783_CR10","first-page":"1","volume":"00","author":"XL Bu","year":"2017","unstructured":"Bu XL, Xiang Y, Jin WS et al (2017) Blood-derived amyloid-\u03b2 protein induces Alzheimer\u2019s disease pathologies. Mol Psychiatry 00:1\u20139","journal-title":"Mol Psychiatry"},{"key":"783_CR11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M Chen","year":"1995","unstructured":"Chen M, Inestrosa NC, Ross GS et al (1995) Platelets are the primary source of amyloid\u03b2-peptide in human blood. Biochem Biophys Res Commun 213:96\u2013103","journal-title":"Biochem Biophys Res Commun"},{"key":"783_CR12","doi-asserted-by":"crossref","first-page":"11993","DOI":"10.1073\/pnas.91.25.11993","volume":"91","author":"M Citron","year":"1994","unstructured":"Citron M, Vigo-Pelfrey C, Teplow DB et al (1994) Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A 91:11993\u201311997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"783_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13550280600760677","volume":"12","author":"A Daily","year":"2006","unstructured":"Daily A, Nath A, Hersh LB (2006) Tat peptides inhibit neprilysin. J Neurovirol 12:153\u2013160","journal-title":"J Neurovirol"},{"key":"783_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720507780362245","volume":"4","author":"R Deane","year":"2007","unstructured":"Deane R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer\u2019s disease. Curr Alzheimer Res 4:191\u2013197","journal-title":"Curr Alzheimer Res"},{"key":"783_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV (2009) Clearance of amyloid-\u03b2 peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 8:16\u201330","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphys.2013.00045","volume":"4","author":"A El Ali","year":"2013","unstructured":"El Ali A, Rivest S (2013) The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease. Front Physiol 4:45. \nhttps:\/\/doi.org\/10.3389\/fphys.2013.00045","journal-title":"Front Physiol"},{"key":"783_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS (1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65:29\u201333","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"783_CR18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jnr.10745","volume":"74","author":"G Evin","year":"2003","unstructured":"Evin G, Zhu A, Holsinger RM et al (2003) Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets. J Neurosci Res 74:386\u2013392","journal-title":"J Neurosci Res"},{"key":"783_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gissl\u00e9n","year":"2009","unstructured":"Gissl\u00e9n M, Krut J, Andreasson U et al (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9:63","journal-title":"BMC Neurol"},{"key":"783_CR20","first-page":"260","volume":"1","author":"B Giunta","year":"2008","unstructured":"Giunta B, Zhou Y, Hou H et al (2008) HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide. Int J Clin Exp Pathol 1:260\u2013275","journal-title":"Int J Clin Exp Pathol"},{"key":"783_CR21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Crook JE, Lucas J et al (2007) Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64:354\u2013362","journal-title":"Arch Neurol"},{"key":"783_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV et al (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407\u2013411","journal-title":"AIDS"},{"key":"783_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molcel.2016.03.019","volume":"62","author":"AM Gross","year":"2016","unstructured":"Gross AM, Jaeger PA, Kreisberg JF et al (2016) Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA. Mol Cell 62:157\u2013168","journal-title":"Mol Cell"},{"key":"783_CR24","unstructured":"Hamel F (2007) HIV Protease inhibitors inhibit insulin-degrading enzyme (IDE) function. 67th Scientific Sessions. American Diabetes Association, Chicago, (poster 2624)"},{"key":"783_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"783_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0b013e31825a3668","volume":"60","author":"Kevin P. High","year":"2012","unstructured":"High KP, Brennan-Ing M, Clifford DB et al (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 60:S1\u2013S18","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"783_CR27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neurobiolaging.2006.11.003","volume":"29","author":"JA Johnston","year":"2008","unstructured":"Johnston JA, Liu WW, Coulson DT et al (2008) Platelet beta-secretase activity is increased in Alzheimer\u2019s disease. Neurobiol Aging 29:661\u2013668","journal-title":"Neurobiol Aging"},{"key":"783_CR28","first-page":"23","volume":"32","author":"R van der Kant","year":"2015","unstructured":"van der Kant R, Goldstein LSB (2015) Cellular functions of the amyloid precursor protein from development to dementia. Dev Cell 32:23","journal-title":"Dev Cell"},{"issue":"8","key":"783_CR29","doi-asserted-by":"crossref","first-page":"e77972","DOI":"10.1371\/journal.pone.0077972","volume":"29","author":"J Kim","year":"2013","unstructured":"Kim J, Yoon JH, Kim YS (2013) HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein. PLoS One 29(8):e77972","journal-title":"PLoS One"},{"key":"783_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R, Khondoker M, Magill N, Stewart R, Landau S (2018) A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord 45:131\u2013151","journal-title":"Dement Geriatr Cogn Disord"},{"key":"783_CR31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00415-012-6688-y","volume":"260","author":"JJ Krut","year":"2013","unstructured":"Krut JJ, Zetterberg H, Blennow K et al (2013) Cerebrospinal fluid Alzheimer\u2019s biomarker profiles in CNS infections. J Neurol 260:620\u2013626","journal-title":"J Neurol"},{"key":"783_CR32","unstructured":"Krut JJ, Gisslen M, Hagberg L, et al (2014) Hyperphosphorylated Tau in cerebrospinal fluid: a biomarker for neurological aging in HIV? Program and abstracts of the 21th Conference on Retroviruses and Opportunistic Infections; Boston, MA. 3-6 March (poster 453)"},{"key":"783_CR33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","volume":"156","author":"YM Kuo","year":"2000","unstructured":"Kuo YM, Kokjohn TA, Watson MD et al (2000) Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol 156:797\u2013805","journal-title":"Am J Pathol"},{"key":"783_CR34","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.4049\/jimmunol.1100211","volume":"186","author":"X Lan","year":"2011","unstructured":"Lan X, Xu J, Kiyota T et al (2011) HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. J Immunol 186:6925\u20136932","journal-title":"J Immunol"},{"key":"783_CR35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11481-011-9304-5","volume":"7","author":"X Lan","year":"2012","unstructured":"Lan X, Kiyota T, Hanamsagar R et al (2012) The effect of HIV protease inhibitors on amyloid-\u03b2 peptide degradation and synthesis in human cells and Alzheimer\u2019s disease animal model. J NeuroImmune Pharmacol 7:412\u2013423","journal-title":"J NeuroImmune Pharmacol"},{"key":"783_CR36","unstructured":"Letendre S, Ellis R, Deutsch R, et al (2010) Correlates of time-to-loss-of-viral response in CSF and plasma in the CHARTER cohort. Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA. 16\u201319 February (poster 430)"},{"key":"783_CR37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","volume":"55","author":"P Lewczuk","year":"2017","unstructured":"Lewczuk P, Matzenc A, Blennowd K et al (2017) Cerebrospinal fluid AB42\/40 corresponds better than AB42 to amyloid PET in Alzheimer\u2019s disease. J Alzheimers Dis 55:813\u2013822","journal-title":"J Alzheimers Dis"},{"key":"783_CR38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000110739","volume":"24","author":"WW Liu","year":"2007","unstructured":"Liu WW, Todd S, Craig D et al (2007) Elevated platelet beta-secretase activity in mild cognitive impairment. Dement Geriatr Cogn Disord 24:464\u2013468","journal-title":"Dement Geriatr Cogn Disord"},{"key":"783_CR39","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","volume":"70","author":"OL Lopez","year":"2008","unstructured":"Lopez OL, Kuller LH, Mehta PD et al (2008) Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 70:1664\u20131671","journal-title":"Neurology"},{"key":"783_CR40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jnen\/61.1.85","volume":"61","author":"JL Mankowski","year":"2002","unstructured":"Mankowski JL, Queen SE, Tarwater PM et al (2002) Accumulation of b-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 61:85\u201390","journal-title":"J Neuropathol Exp Neurol"},{"key":"783_CR41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QAI.0b013e3181b79aff","volume":"52","author":"KM Marks","year":"2009","unstructured":"Marks KM, Clarke RM, Bussel JB et al (2009) Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr 52:595\u2013599","journal-title":"J Acquir Immune Defic Syndr"},{"key":"783_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269","journal-title":"Alzheimers Dement"},{"key":"783_CR43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttila T, Mehta SP et al (2000) Plasma and cerebrospinal fluid levels of amyloid BProteins 1\u201340 and 1\u201342 in Alzheimer disease. Arch Neurol 57:100\u2013105","journal-title":"Arch Neurol"},{"key":"783_CR44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-130203","volume":"36","author":"JL Molinuevo","year":"2013","unstructured":"Molinuevo JL, Gispert JD, Dubois B et al (2013) The AD-CSF-Index discriminates Alzheimer\u2019s disease patients from healthy controls: a validation study. J Alzheimers Dis 36:67\u201377","journal-title":"J Alzheimers Dis"},{"key":"783_CR45","doi-asserted-by":"crossref","first-page":"e0144312","DOI":"10.1371\/journal.pone.0144312","volume":"10","author":"S Mooney","year":"2015","unstructured":"Mooney S, Tracy R, Osler T et al (2015) Elevated biomarkers of inflammation and coagulation in patients with HIV are associated with higher Framingham and VACS risk index scores. PLoS One 10:e0144312","journal-title":"PLoS One"},{"key":"783_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002030-200501280-00013","volume":"19","author":"A Nath","year":"2005","unstructured":"Nath A, Hersh LB (2005) Tat and amyloid: multiple interactions. AIDS 19:203\u2013204","journal-title":"AIDS"},{"key":"783_CR47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0000000000000174","volume":"28","author":"N Noel","year":"2014","unstructured":"Noel N, Boufassa F, Lecuroux C et al (2014) Elevated IP10 levels are associated with immune activation and low CD4(+) T-cell counts in HIV controller patients. AIDS 28:467\u2013476","journal-title":"AIDS"},{"key":"783_CR48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"M van Oijen","year":"2006","unstructured":"van Oijen M, Hofman A, Soares HD et al (2006) Plasma Abeta(1\u201340) and Abeta(1\u201342) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5:655\u2013660","journal-title":"Lancet Neurol"},{"key":"783_CR49","doi-asserted-by":"publisher","first-page":"e116081","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H et al (2014) Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 9:e116081. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0116081","journal-title":"PLoS One"},{"key":"783_CR50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11481-009-9151-9","volume":"4","author":"L Pulliam","year":"2009","unstructured":"Pulliam L (2009) HIV regulation of amyloid beta production. J NeuroImmune Pharmacol 4:213\u2013217","journal-title":"J NeuroImmune Pharmacol"},{"key":"783_CR51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0956462415624075","volume":"28","author":"SM Raboni","year":"2017","unstructured":"Raboni SM, Ribeiro CE, Almeida SM et al (2017) Impact of public health strategies on reducing AIDS mortality in southern Brazil. Int J STD AIDS 28:54\u201362","journal-title":"Int J STD AIDS"},{"key":"783_CR52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel HC, Pulliam L (2005) HIV-1Tat inhibits neprilysin and elevates amyloid beta. AIDS 19:127\u2013135","journal-title":"AIDS"},{"key":"783_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/alzrt162","volume":"5","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Shaw LM, Trojanowski JQ (2013) Plasma amyloid beta measurements\u2014a desired but elusive Alzheimer\u2019s disease biomarker. Alzheimers Res Ther 5:8. \nhttps:\/\/doi.org\/10.1186\/alzrt162","journal-title":"Alzheimers Res Ther"},{"key":"783_CR54","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1194\/jlr.M200487-JLR200","volume":"44","author":"H Tran","year":"2003","unstructured":"Tran H, Robinson S, Mikhailenko I et al (2003) Modulation of the LDL receptor and LRP levels by HIV protease inhibitors. J Lipid Res 44:1859\u20131869","journal-title":"J Lipid Res"},{"key":"783_CR55","first-page":"20","volume":"8","author":"WE Van Nostrand","year":"2001","unstructured":"Van Nostrand WE, Melchor JP (2001) Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells. Amyloid 8:20\u201327","journal-title":"Amyloid"},{"key":"783_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-017-0324-0","volume":"9","author":"MJ Wang","year":"2017","unstructured":"Wang MJ, Yi SH, Han J et al (2017) Oligomeric forms of amyloid-\u03b2 protein in plasma as a potential blood-based biomarker for Alzheimer\u2019s disease. Alzheimers Res Ther 9:98","journal-title":"Alzheimers Res Ther"},{"key":"783_CR57","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2004.12.013","volume":"18","author":"JA White","year":"2005","unstructured":"White JA, Manelli AM, Holmberg KH et al (2005) Differential effects of oligomeric and fibrillar amyloid-beta 1\u201342 on astrocyte-mediated inflammation. Neurobiol Dis 18:459\u2013465","journal-title":"Neurobiol Dis"},{"key":"783_CR58","doi-asserted-by":"crossref","DOI":"10.1201\/9781420010404","volume-title":"Generalized additive models: an introduction with R","author":"SN Wood","year":"2006","unstructured":"Wood SN (2006) Generalized additive models: an introduction with R. CRC Press, LLC, Boca Raton"},{"key":"783_CR59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11481-008-9136-0","volume":"4","author":"J Xu","year":"2009","unstructured":"Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease: a foreseeable medical challenge in post-HAART era. J NeuroImmune Pharmacol 4:200\u2013212","journal-title":"J NeuroImmune Pharmacol"},{"key":"783_CR60","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11481-011-9259-6","volume":"6","author":"J Zhang","year":"2011","unstructured":"Zhang J, Liu J, Katafiasz B et al (2011) HIV-1 gp120- induced axonal injury detected by accumulation of beta-amyloid precursor protein in adult rat corpus callosum. J NeuroImmune Pharmacol 6:650\u2013657","journal-title":"J NeuroImmune Pharmacol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-019-00783-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T23:03:59Z","timestamp":1593990239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-019-00783-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00783-6","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,7]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}